Literature DB >> 27224890

Role of the tumor microenvironment in regulating apoptosis and cancer progression.

Katherine Yaacoub1, Remy Pedeux2, Karin Tarte3, Thierry Guillaudeux4.   

Abstract

Apoptosis is a gene-directed program that is engaged to efficiently eliminate dysfunctional cells. Evasion of apoptosis may be an important gate to tumor initiation and therapy resistance. Like any other developmental program, apoptosis can be disrupted by several genetic aberrations driving malignant cells into an uncontrolled progression and survival. For its sustained growth, cancer develops in a complex environment, which provides survival signals and rescues malignant cells from apoptosis. Recent studies have clearly shown a wide interaction between tumor cells and their microenvironment, confirming the influence of the surrounding cells on tumor expansion and invasion. These non-malignant cells not only intensify tumor cells growth but also upgrade the process of metastasis. The strong crosstalk between malignant cells and a reactive microenvironment is mediated by soluble chemokines and cytokines, which act on tumor cells through surface receptors. Disturbing the microenvironment signaling might be an encouraging approach for patient's treatment. Therefore, the ultimate knowledge of "tumor-microenvironment" interactions facilitates the identification of novel therapeutic procedures that mobilize cancer cells from their supportive cells. This review focuses on cancer progression mediated by the dysfunction of apoptosis and by the fundamental relationship between tumor and reactive cells. New insights and valuable targets for cancer prevention and therapy are also presented.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Immune escape; Inflammation; Microenvironment; Resistance

Mesh:

Substances:

Year:  2016        PMID: 27224890     DOI: 10.1016/j.canlet.2016.05.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  30 in total

1.  Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.

Authors:  Christopher J Pirozzi; Austin B Carpenter; Matthew S Waitkus; Catherine Y Wang; Huishan Zhu; Landon J Hansen; Lee H Chen; Paula K Greer; Jie Feng; Yu Wang; Cheryl B Bock; Ping Fan; Ivan Spasojevic; Roger E McLendon; Darell D Bigner; Yiping He; Hai Yan
Journal:  Mol Cancer Res       Date:  2017-02-01       Impact factor: 5.852

2.  Repeated exposure of epithelial cells to apoptotic cells induces the specific selection of an adaptive phenotype: Implications for tumorigenesis.

Authors:  Lanfei Feng; Snezana Vujicic; Michael E Dietrich; Natalia Litbarg; Suman Setty; Angelika Antoni; Joyce Rauch; Jerrold S Levine
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

Review 3.  Mechanism of interaction between autophagy and apoptosis in cancer.

Authors:  Shreya Das; Nidhi Shukla; Shashi Shekhar Singh; Sapana Kushwaha; Richa Shrivastava
Journal:  Apoptosis       Date:  2021-09-12       Impact factor: 4.677

4.  Embryonic stem cell secreted factors decrease invasiveness of triple-negative breast cancer cells through regulome modulation.

Authors:  Elizabeth Tarasewicz; Robert S Oakes; Misael O Aviles; Joelle Straehla; Kathryn M Chilton; Joseph T Decker; Jia Wu; Lonnie D Shea; Jacqueline S Jeruss
Journal:  Cancer Biol Ther       Date:  2018-03-13       Impact factor: 4.742

5.  Seleno-β-lactoglobulin (Se-β-Lg) induces mitochondria-dependant apoptosis in HepG2 cells.

Authors:  Hai-Yu Ji; Juan Yu; An-Jun Liu
Journal:  Mol Biol Rep       Date:  2019-07-30       Impact factor: 2.316

Review 6.  Exosomal microRNAs in hepatocellular carcinoma.

Authors:  Chenbin Liu; Han Wu; Yinqi Mao; Wei Chen; Shuying Chen
Journal:  Cancer Cell Int       Date:  2021-05-08       Impact factor: 5.722

7.  Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma.

Authors:  Zhijing Mo; Shunxin Zheng; Zhilue Lv; Yuan Zhuang; Xiuwan Lan; Feng Wang; Xiaoling Lu; Yongxiang Zhao; Sufang Zhou
Journal:  Sci Rep       Date:  2016-12-19       Impact factor: 4.379

Review 8.  Exploitation of Apoptotic Regulation in Cancer.

Authors:  David S Ucker; Jerrold S Levine
Journal:  Front Immunol       Date:  2018-02-27       Impact factor: 7.561

9.  Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death.

Authors:  So Jung Park; Doo Sin Jo; Se-Young Jo; Dong Woon Shin; Sangmi Shim; Yoon Kyung Jo; Ji Hyun Shin; Ye Jin Ha; Seong-Yun Jeong; Jung Jin Hwang; Young Sam Kim; Young-Ah Suh; Jong Wook Chang; Jin Cheon Kim; Dong-Hyung Cho
Journal:  Oncotarget       Date:  2016-10-04

10.  CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.

Authors:  Shanmugapriya Thangavadivel; Claudia Zelle-Rieser; Angelika Olivier; Benno Postert; Gerold Untergasser; Johann Kern; Andrea Brunner; Eberhard Gunsilius; Rainer Biedermann; Roman Hajek; Ludek Pour; Wolfgang Willenbacher; Richard Greil; Karin Jöhrer
Journal:  Oncotarget       Date:  2016-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.